This report provides an update on the use of harm reduction in tobacco smoking, in relation to all non-tobacco nicotine products but particularly e-cigarettes. It shows that, for all the potential risks involved, harm reduction has huge potential to prevent death and disability from tobacco use and to hasten our progress to a tobacco-free society.
Following reported deaths and disease in the US linked to vaping, see the RCP’s position statement on the differing situations in the US and UK and our continuing advice to current smokers that vaping is still far less harmful than smoking tobacco.
- Smoking is the biggest avoidable cause of death and disability, and social inequality in health, in the UK.
- Provision of the nicotine that smokers are addicted to without the harmful components of tobacco smoke can prevent most of the harm from smoking.
- Nicotine replacement therapy (NRT) is most effective in helping people to stop smoking when used together with health professional input and support, but much less so when used on its own.
- E-cigarettes are marketed as consumer products and are proving much more popular than NRT as a substitute and competitor for tobacco cigarettes.
- E-cigarettes appear to be effective when used by smokers as an aid to quitting smoking.
- E-cigarettes are not currently made to medicines standards and are probably more hazardous than NRT.
- However, the hazard to health arising from long-term vapour inhalation from the e-cigarettes available today is unlikely to exceed 5% of the harm from smoking tobacco.
- Technological developments and improved production standards could reduce the long-term hazard of e-cigarettes.
- There are concerns that e-cigarettes will increase tobacco smoking by renormalising the act of smoking, acting as a gateway to smoking in young people, and being used for temporary, not permanent, abstinence from smoking.
- However, the available evidence to date indicates that e-cigarettes are being used almost exclusively as safer alternatives to smoked tobacco, by confirmed smokers who are trying to reduce harm to themselves or others from smoking, or to quit smoking completely.
- There is a need for regulation to reduce direct and indirect adverse effects of e-cigarette use, but this regulation should not be allowed significantly to inhibit the development and use of harm-reduction products by smokers.
- However, in the interests of public health it is important to promote the use of e-cigarettes, NRT and other non-tobacco nicotine products as widely as possible as a substitute for smoking in the UK.
'The next steps in the long journey to tobacco harm reduction' - Professor John Britton, the RCP's special adviser on tobacco, reflects on recent developments in tobacco control and the introduction of standardised packaging.
Harm reduction in nicotine addiction: helping people who can't quit - A report by the Tobacco Advisory Group of the RCP, published in October 2007, which argued for the application of harm-reduction strategies to tobacco dependence.
- Smoking and health - The 1962 RCP report that highlighted the link between smoking and lung cancer, other lung diseases, heart disease, and gastrointestinal problems.